Bevacizumab Increases Risk for Severe Proteinuria in Cancer Patients

Journal of the American Society of Nephrology : JASN - United States
doi 10.1681/asn.2010020167
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

Effect of a Single Intravitreal Bevacizumab Injection on Proteinuria in Patients With Diabetes

Translational Vision Science and Technology
OphthalmologyBiomedical Engineering
2020English

Incidence and Risk of Proteinuria With Aflibercept in Cancer Patients: A Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Congestive Heart Failure Risk in Patients With Breast Cancer Treated With Bevacizumab

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Increased Risk of Cerebrovascular Events in Patients With Cancer Treated With Bevacizumab: A Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Young Age Increases the Risk for Lymph Node Metastasis in Patients With Early Colon Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Severe Phenotype of APECED (APS1) Increases Risk for Structural Bone Alterations

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2020English

Understanding How Smoking Increases Cancer Risk

Cancer Discovery
Oncology
2016English

The Risk and Predictors for Severe Radiation Pneumonitis in Lung Cancer Patients Treated With Thoracic Reirradiation

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2018English

Incidence and Risk of Severe Neutropenia in Advanced Cancer Patients Treated With Cetuximab

Drugs in R and D
Pharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy